HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-1.63%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.83B
AUM Growth
+$2.83B
(-7.7%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-6.59%
Top 10 Holdings %
Top 10 Hldgs %
54.57%
Holding
55
New
19
Increased
10
Reduced
13
Closed
12
Top Buys
| 1 |
Dentsply Sirona
XRAY
|
$145M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$103M |
| 3 |
Zimmer Biomet
ZBH
|
$87.2M |
| 4 |
Agilent Technologies
A
|
$70.5M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$68.3M |
Top Sells
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$202M |
| 2 |
Medtronic
MDT
|
$147M |
| 3 |
Incyte
INCY
|
$102M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$93.7M |
| 5 |
CELG
Celgene Corp
CELG
|
$93.1M |
Sector Composition
| 1 | Healthcare | 93.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zimmer Biomet
ZBH
$21B
| $254M | 8.62% | 2,325,000 +800,000 | +52% | +$87.2M |
|
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $215M | 7.32% | 625,000 +300,000 | +92% | +$103M |
|
3
Merck
MRK
$210B
| $199M | 6.78% | 3,657,820 -242,180 | -6% | -$13.2M |
|
4
Labcorp
LH
$23.1B
| $170M | 5.78% | 1,050,000 -50,000 | -5% | -$8.09M |
|
|
5
Dentsply Sirona
XRAY
$2.85B
| $145M | 4.92% | +2,875,000 | New | +$145M |
|
6
Baxter International
BAX
$12.7B
| $138M | 4.7% | 2,124,670 +399,670 | +23% | +$26M |
|
7
UnitedHealth
UNH
$281B
| $133M | 4.52% | 620,480 +305,480 | +97% | +$65.4M |
|
8
Intuitive Surgical
ISRG
$170B
| $117M | 3.97% | 282,420 +60,950 | +28% | +$25.2M |
|
9
LivaNova
LIVN
$3.08B
| $95.1M | 3.24% | 1,075,000 +452,003 | +73% | +$40M |
|
10
Pediatrix Medical
MD
$1.5B
| $76.9M | 2.62% | 1,383,200 +121,580 | +10% | +$6.76M |
|
11
Pacira BioSciences
PCRX
$1.2B
| $71.6M | 2.44% | 2,300,000 -500,000 | -18% | -$15.6M |
|
|
12
Agilent Technologies
A
$35.7B
| $70.5M | 2.4% | +1,054,000 | New | +$70.5M |
|
|
RDUS
13
DELISTED
Radius Health, Inc.
RDUS
| $68.3M | 2.32% | +1,900,000 | New | +$68.3M |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $65.1M | 2.21% | +1,200,000 | New | +$65.1M |
|
15
Qiagen
QGEN
$10.1B
| $64.8M | 2.21% | +2,006,840 | New | +$64.8M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $60.8M | 2.07% | 681,030 -1,043,970 | -61% | -$93.1M |
|
17
Elevance Health
ELV
$71.8B
| $59M | 2.01% | 268,770 -47,410 | -15% | -$10.4M |
|
18
Neurocrine Biosciences
NBIX
$13.8B
| $57.4M | 1.95% | 691,595 -833,405 | -55% | -$69.1M |
|
19
Danaher
DHR
$147B
| $55.6M | 1.89% | 567,960 +443,300 | +356% | +$43.4M |
|
20
AbbVie
ABBV
$372B
| $54.3M | 1.85% | 574,070 -175,340 | -23% | -$16.6M |
|
21
IQVIA
IQV
$32.4B
| $54.1M | 1.84% | 550,930 -232,450 | -30% | -$22.8M |
|
22
Masimo
MASI
$7.59B
| $50.6M | 1.72% | +575,000 | New | +$50.6M |
|
23
Gilead Sciences
GILD
$140B
| $49.5M | 1.68% | +656,690 | New | +$49.5M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $49.1M | 1.67% | 291,520 -533,480 | -65% | -$89.8M |
|
25
Bristol-Myers Squibb
BMY
$96B
| $38M | 1.29% | 601,080 +196,410 | +49% | +$12.4M |
|